Videos and podcasts

Listen and watch experts talk about key topics within Oncology, from challenging case studies, to key treatment data.

Therapy area
Lung cancer
Non-small cell lung cancer
Lymphoma
Cutaneous T-cell lymphoma
Hodgkin lymphoma
Peripheral T-cell lymphoma
Multiple Myeloma
Sort by: Most recent
Sort by: Popularity
Sort by: Title
Initiating Patient_Clark
Prescribing information Alunbrig
ALUNBRIG® (brigatinib) Expert Opinion Video Series: Initiating patients on ALUNBRIG

Listen to Dr Brian Clark share his experience of initiating ALUNBRIG in patients with ALK+ aNSCLC to gain insight that can be translated into your own clinical practice. 

Dr Clark discusses the recommended ALUNBRIG dosing regimen, and highlights the availability of the starter pack and provision of the patient alert card for your patients with ALK+ aNSCLC.

 

Managing Toxicities_Ghosh
Prescribing information Alunbrig
ALUNBRIG® (brigatinib) Expert Opinion Video Series: Managing toxicities and side effects associated with ALUNBRIG

Listen to Dr Sharmistha Ghosh who shares her experience on the management of patients with ALK+ aNSCLC during treatment with ALUNBRIG, including the specific monitoring required. 

Jackson_Lenalidomide Rechallenge
Prescribing information Ninlaro
How can we determine whether lenalidomide rechallenge is an option for patients with RRMM?

Lenalidomide has become an integral part of first-line treatment in patients with multiple myeloma.1 As patients progress to later lines, options can become limited, and the choice of treatment offered in patients who relapse should be carefully evaluated.2 Defining and understanding the lenalidomide status of patients with multiple myeloma can help guide the next line of treatment and which patients can be rechallenged appropriately with lenalidomide post relapse.